ANZBSM ASM 2006 Program

Scientific Program - Invited Lectures & Speakers

Invited Plenary Lectures

• Cellular Symphony of Osteoclastogenesis
  • Osteoblast and osteoclasts: local communication through several mechanisms
    T. Jack Martin (Australia)
    Abstract (74KB)
  • Immune mechanisms in osteoclastogenesis
    Hiroshi Takayanagi (Japan)
    Abstract (77KB)
  • Bone remodelling and the roles of nuclear receptor
    Shigekai Kato, Takashi Nakamura, Takashi Sato and Yoko Yamamoto (Japan)
    Abstract (68KB)
  • Mesenchymal/haemopoietic interactions in osteoclastogenesis
    Nobuyuki Udagawa (Japan)
    Abstract (64KB)
• Growth
  • Growth related origins of bone disease
    Hiroyuki Tanaka (Japan)
    Abstract (63 KB)
  • Growth - choosing the right parents
    Cyrus Cooper (UK)
    Abstract (71KB)
  • Signalling for cartilage differentiation
    Toshihisa Komori (Japan)
    Abstract (72KB)
  • Bone health in chronic disease: evaluation and treatment - a paediatric perspective
    Mary Leonard (USA)
    Abstract (72KB)
• Epidemiology and Genetics
  • Genetics of osteoporosis – what are the questions? How to answer them?
    Hongwen Deng (USA)
    Abstract (74KB)
  • Genetics of osteoporosis – how to get the answers?
    Matthew Brown (Australia)
    Abstract (64KB)
  • Central control of bone mass
    Edith Gardiner (Australia)
    Abstract (81KB)
• Biomechanics
  • Why bones break – the material and structural basis of bone strength and fragility
    Mark Forwood (Australia)
    Abstract (66KB)
  • Mechanical stress-induced AP-1 and Smad signalling for osteoblastic differentiation
    Daisuke Inoue, Shinsuke Kido and Toshio Matsumoto (Japan)
    Abstract (65KB)
• Epidemiology, Pathogenesis and Cancer
  • Epidemiology of fractures - known and unknown
    Edith Lau (Hong Kong)
    Abstract (67KB)
  • Goodbye T and Z, Welcome to the absolute risk on the Y-axis
    John Kanis (UK)
    Abstract (67KB)
  • Pathogenesis of bone fragility
    Ian Reid (New Zealand)
    Abstract (60KB)
  • Cancer + Bone - New frontier in drug discovery in oncology
    Greg Mundy (USA)
    Abstract (63KB)
• Metabolic Bone Disease
  • Pathophysiology and prevention of arthritic bone destruction
    Evange Romas (Australia)
    Abstract (65KB)
  • Is calcitonin a novel treatment for osteoarthritis?
    M.A Karsdal and Claus Christiansen (Denmark)
    Abstract (92KB)
  • Corticosteroids and bone – mechanisms, treatment
    Cyrus Cooper (UK)
    Abstract (74KB)
  • Myeloma-bone interaction: a vicious cycle
    Toshio Matsumoto and and M. Abe (Japan)
    Abstract (65KB)
  • Unique biological function of fibroblast growth factor (FGF) 23
    Seiji Fukumoto (Japan)
    Abstract (65KB)
• Therapeutics
  • New drugs, new mechanisms (Strontium ranelate, AMG 162, Vitamin K others)
    Pierre Delmas (France)
    Abstract (65KB)
  • Anabolic agents – approaches to The Holy Grail for Bone
    Greg Mundy (USA)
    Abstract (60KB)
  • Future of new Vitamin D analogs
    Kyoji Ikeda (Japan)
    Abstract (71KB)

 

Page content.